Hoey B M, Butler J, Halliwell B
Paterson Institute for Cancer Research, Christie Hospital and Holt Radium Institute, Manchester, UK.
Free Radic Res Commun. 1988;4(4):259-63. doi: 10.3109/10715768809055151.
Allopurinol has been employed as a "specific" inhibitor of xanthine oxidase in studies of hypoxic/reoxygenation injury. Pulse radiolysis was used to establish rate constants for the reactions of allopurinol and its major metabolite oxypurinol with hydroxyl radicals: values were (1.45 +/- 0.24) x 10(9) M-1 s-1 for allopurinol and (4.95 +/- 0.84) x 10(9) M-1 s-1 for oxypurinol. These rate constants show that, in view of the amounts of allopurinol that have been used in animal studies, hydroxyl radical scavenging by this molecule could contribute to its biological actions, especially if animals are pre-treated with allopurinol, so allowing oxypurinol to form. The ability of allopurinol to protect tissues not containing xanthine oxidase against reoxygenation injury may be related to radical scavenging by allopurinol and oxypurinol.
在低氧/复氧损伤研究中,别嘌醇已被用作黄嘌呤氧化酶的“特异性”抑制剂。脉冲辐解用于确定别嘌醇及其主要代谢产物氧嘌呤醇与羟基自由基反应的速率常数:别嘌醇的值为(1.45±0.24)×10⁹ M⁻¹ s⁻¹,氧嘌呤醇的值为(4.95±0.84)×10⁹ M⁻¹ s⁻¹。这些速率常数表明,鉴于在动物研究中使用的别嘌醇量,该分子清除羟基自由基可能有助于其生物学作用,特别是如果动物预先用别嘌醇处理,从而使氧嘌呤醇形成。别嘌醇保护不含黄嘌呤氧化酶的组织免受复氧损伤的能力可能与别嘌醇和氧嘌呤醇清除自由基有关。